Financial News
Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)
Headline News about Sarepta Therapeutics, Inc. - Common Stock

The Latest Analyst Ratings for Sarepta Therapeutics
December 12, 2023
Via Benzinga



Analyst Ratings for Sarepta Therapeutics
November 21, 2023
Via Benzinga




Analyst Ratings for Sarepta Therapeutics
November 02, 2023
Via Benzinga



Jim Cramer Likes Founder Of AI Company, But Stock Is 'Losing A Fortune' And There's 'Too Much Hype There'
November 15, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence



8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
Via Benzinga


Sarepta Therapeutics (SRPT) Q3 2023 Earnings Call Transcript
November 02, 2023
Via The Motley Fool
Topics
Earnings
Exposures
Financial





12 Health Care Stocks Moving In Tuesday's Intraday Session
October 31, 2023
Via Benzinga



US Stocks Fall; Pfizer Swings To Q3 Loss
October 31, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities



12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 31, 2023
Via Benzinga

Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
October 31, 2023
Via Benzinga
Exposures
Product Safety

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.